The pharmacology of blinatumomab: state of the art on pharmacodynamics, pharmacokinetics, adverse drug reactions and evaluation in clinical trials.

Pauline MocquotYasmine MossazadehLéopoldine LapierreFanny PineauFabien Despas

Published in: Journal of clinical pharmacy and therapeutics (2022)

This review summarizes the current knowledge of blinatumomab in the literature. The subject of many CTs is to improve the route of administration and expand the indications for treatment.

Keyphrases

adverse drug
acute lymphoblastic leukemia
clinical trial
systematic review
healthcare
emergency department
randomized controlled trial
drug induced
combination therapy
phase iii